Dr. Martens sees Q3 sales increase, positive outlook for future

From Investing.com: 2025-01-27 03:24:22

Dr. Martens reports a modest sales increase in Q3, with group revenue up by 3% at constant currency to £267 million. Direct-to-consumer revenue grew by 1%, driven by a 2% rise in ecommerce sales. Wholesale revenue saw a stronger recovery, increasing by 9% at constant currency, with gains in EMEA and APAC.

Analysts believe Dr. Martens may be nearing the bottom of its earnings cycle in 2024-2025, with a new CEO and CFO offering a better outlook. APAC stood out with a 17% increase in DTC revenue, while EMEA saw a 5% decline due to promotional activity. Americas showed signs of recovery with a 4% rise in DTC revenue.

Dr. Martens CEO remains optimistic about FY25 outlook, noting progress in turning around USA performance. The company is actively managing costs and expects to meet its inventory reduction target. Despite challenges in retail, growth in ecommerce and the U.S. market boosts confidence in the brand’s strategy.

Dr. Martens maintains guidance for FY25, signaling progress towards objectives. Analysts anticipate technical boots segment may outperform casual boots due to changing consumer habits. Overall, the brand’s value remains strong, but demand for boots is challenging to predict in the near term.



Read more at Investing.com: Dr. Martens posts Q3 sales rise, US recovery gains traction By Investing.com